SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mason Barge who wrote (134)8/6/1998 11:31:00 PM
From: Thomas Kirwin   of 422
 
ABS2000 Placement Clock

Mason,

The Immucor Media/Investor Kit that I received included a different version of the July 6th ABS2000 FDA approval press release as is evident by this eye opening statement regarding future sales.

"There are more than 2500 facilities in the United States that can benefit from the quality and productivity improvements provided by the ABS2000 system. With no competition in automation for blood banks, Immucor has a distinct competitive advantage in the hospital transfusion service market, and expects to have the first ABS2000 systems installed within the next 60 days"

Looks like we should see some news by September 5th!

Regards,

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext